Company plans Phase 2 trial in first-recurrence head & neck cancer, in combination with immune checkpoint inhibitor ATLANTA, GA, July 31, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (NASDAQ:GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious diseases, today announced the next steps for the clinical development of its Gedeptin® cancer therapy, following a clinical advisory committee review. GeoVax and a specially convened clinical advisory commit ...

Results affirm expectation of a novel mechanism of action targeting astrocyte activation to delay progression of Alzheimer's disease from early stage Mild Cognitive Impairment Findings echo previous phase 2 results in Huntington's disease based on similarities to neuroimmune pathology in Alzheimer's ROCHESTER, N.Y., July 31, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (NASDAQ:VCNX), a clinical-stage biotechnology company pioneering treatment of Alzheimer's disease (AD) with anti-Semaphorin 4D (SEMA4D) antibody, ...

RALEIGH, N.C., July 31, 2024 /PRNewswire/ -- First Citizens Bank today announced that its Middle Market Banking business provided $25 million in financing to F.W. Webb, the largest wholesale distributor of plumbing, heating and industrial products in the Northeastern U.S. The closing of this financing coincides with the announcement that First Citizens Middle Market Banking is expanding its banking services and capabilities to serve midsize business clients across the Northeast. A third generation privately ...

Reverse Stock-Split to be effective on August 2, 2024 VANCOUVER, BC, July 31, 2024 /PRNewswire/ -- Siyata Mobile Inc. (Nasdaq: SYTA, SYTAW) ("Siyata" or the "Company"), a global vendor of Push-to-Talk over Cellular (PoC) devices and cellular signal booster systems, today announced that it will effect a 1-for-18 reverse stock split ("Reverse Stock Split") of its common share, no par value per share ("Common Share"). The Reverse Stock Split will become effective at 12:01 a.m. Eastern Time on Friday, August 2, ...

Meeting Insights employs conversational AI to transform how organizations manage and leverage crucial information from Microsoft Teams meetings OR YEHUDA, Israel, July 31, 2024 /PRNewswire/ -- Highlights Meeting Insights is part of AudioCodes' growing offering of SaaS applications designed to meet evolving market demands for more flexible, scalable and integrated solutions for the modern workplace. The award's judges recognized Meeting Insights' ability to leverage conversational AI to enhance users' produ ...

Strong Business Results, Top Global Employer Recognition, and Leading Portfolio of Partner Brands Reflect Synchrony's Central Role in Driving Economic Growth a Decade After IPO Celebrates with Additional $1 Million in Grants to Nonprofits Globally through Employee-Directed Program STAMFORD, Conn., July 31, 2024 /PRNewswire/ -- Synchrony (NYSE: SYF), a leading financing partner for many of America's most iconic brands, is celebrating 10 years as a publicly traded company. From health to home, retail to whole ...

HOBOKEN, N.J., July 31, 2024 /PRNewswire/ -- Back-to-School season is upon us, and with it comes back-topacking-lunches, back-to-carpools and back-to-back commitments for busy parents and kids. In fact, 8 in 10 parents plan to enroll their children in extracurricular activities this school season1. As families gear up for another school year, leading health and wellness company Hain Celestial Group (Nasdaq: HAIN) is here to provide delicious and convenient better-for-you snacking and meal prep solutions to ...

Alcyone's ThecaFlex is an implantable medical device under investigation for routine subcutaneous administration of therapeutics to the cerebrospinal fluid (CSF). The first stage of the pivotal IDE PIERRE trial has been completed. 10 spinal muscular atrophy (SMA) patients have undergone ThecaFlex implantation and have received nusinersen through the device. No device-related adverse events, including infections, were observed in the 30 days after implantation. FDA has agreed to an additional 80-SMA patient ...

-Company to Host Conference Call, August 7, 2024 at 4:30 p.m. ET- Conference Call Details: SAN DIEGO, July 31, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, will release its financial results for the second quarter ended June 30, 2024, after the market close on Wednesday, August 7, 2024. Management will then host a webcast and conference call at 4:30 p.m. ET on August 7. ...

ASHBURN, Va. and CEDAR RAPIDS, Iowa, July 31, 2024 (GLOBE NEWSWIRE) -- Telos Corporation (NASDAQ:TLS), an authorized enrollment provider, continues to expand locations to enroll and renew consumers in the TSA PreCheck® program by opening a new location at the Eastern Iowa Airport (CID) in Cedar Rapids, Iowa on July 24, 2024. Telos now has 69 TSA PreCheck enrollment centers open across the U.S. The launch of the enrollment center at CID airport represents the ongoing expansion of Telos' national TSA PreCheck ...